Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

Sagar Cements Ltd

SAGCEM
Cement

Sagar Cements Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the P/E sits at the 79th percentile of its own range — the multiple has already done part of the work.

The price is in a downtrend (35 weeks in) while the P/E sits at the 79th percentile of its own 8-year range. Underneath, the last four quarters read deteriorating — profit −500.0% year on year, and 253% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.

Price
₹174
−27.8% 1Y
P/E
127.8×
79th pctile
of its own 8-year range
Revenue (Jun 26)
₹706 Cr
+5.2% YoY
Profit (Jun 26)
₹−28.0 Cr
−500.0% YoY
Operating margin
10.0%
−8.0 pp YoY
ROCE
2%
FY26
Cash conversion
253%
of profit, last 3 FY
Withheld from this page: Part of this page is deliberately not drawn: its two data sources disagree by up to 75% on reported income across 14 comparable periods, so nothing from the second source is placed here — the quarterly PEG curve, the quarterly return curves, the annual return-on-invested-capital overlay, the total-debt and debt-to-equity series and the F-score and the return-on-invested-capital reading are absent for that reason. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data. The quarterly history also begins where the primary source begins: 6 earlier quarters the second source carries are not spliced in front of it. Extending a reported profit series is stricter than showing a ratio chart — it needs a source that has been checked.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Sagar Cements Ltd trades at ₹174, in a downtrend and 35 weeks into that stage. That is −9.6% against its own 200-day average. It sits at 11% of a 52-week range of ₹160 to ₹294. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (17 weeks and counting).

Today the stock is in a downtrend — week 35 of stage 4, confirmed. At ₹174 it trades −9.6% versus its 200-day average and sits at 11% of its 52-week range (₹160–₹294).

Jul 26: ₹174 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−9.6% versus the 200-day line, week 35 of stage 4
Price50-day avg200-day avg
S2S4S4S2S4₹305₹266₹227₹188₹149₹174₹192Jul 23May 24Feb 25Nov 25Jul 26
S2S4S4S2S4₹305₹266₹227₹188₹149₹174₹192Jul 23Feb 25Jul 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (546 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Jul 26

Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +129% while the NIFTY 500 moved +276% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (17 weeks and counting; last ahead the week of 2026-05-08) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Sagar Cements Ltd trades at 127.8× P/E, at the pricey end of its own range (79th percentile). Its long-run median P/E is 31.6×, measured across 7.7 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 127.8× is at the pricey end of its own range (79th percentile), against a long-run median of 31.6× measured over 7.7 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 127.8× vs a 31.6× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 7.7-year window; loss-period spikes above 95× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
at the pricey end of its own range (79th percentile)
P/EMedianEPS (TTM) (quarterly)
101.5×₹18.376.9×₹13.752.3×₹9.127.6×₹4.63.0×₹0.0×94.70×₹2Sep 16Jun 18May 20Dec 21May 24
101.5×₹18.376.9×₹13.752.3×₹9.127.6×₹4.63.0×₹0.0×94.70×₹2Sep 16May 20May 24
P/E
127.8×
79th percentile of 8y

The price move, decomposed: over 5y, of the −7.9%/yr price move, ~+5.2%/yr came from earnings growth and ~−13.1 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources disagree by up to 75% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Sagar Cements Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 8 quarters across 2 curves, on partial evidence.

Growth, year by year: revenue +17.4% in FY26 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
84%348%59%174%34%0.0%8.4%−174%−17%−348%%%17.4%−300%FY16FY21FY26
84%348%59%174%34%0.0%8.4%−174%−17%−348%%%17.4%−300%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating
RevenueProfitEPS
20%−69%12%−131%3.8%−193%−4.2%−255%−12%−317%%%13.4%−300%−300%Sep 23Dec 24Jun 26
20%−69%12%−131%3.8%−193%−4.2%−255%−12%−317%%%13.4%−300%−300%Sep 23Dec 24Jun 26
ROCE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROCE
7.7%5.1%2.5%−0.1%−2.7%%2%FY23FY24FY26
7.7%5.1%2.5%−0.1%−2.7%%2%FY23FY24FY26
Revenue growth
Rising
latest +13.4% · span −9.9% to +17.4%
ROCE
Stuck low
latest 2.0% · span −2.0%–7.0%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+17.4%+5.9%+14.1%+13.4%
Share price−27.8%−5.9%−7.9%+3.3%
Revenue YoY (Jun 26)
+5.2%
latest quarter vs a year ago
Profit YoY (Jun 26)
−500.0%
latest quarter vs a year ago
Revenue 10y
13.4%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

41.0/100 — rank 20 of 26 in Cement · 66% evidence confidence

Sagar Cements Ltd scores 41.0 out of 100 against the 26 companies it is compared with in Cement, ranking 20. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 19.5 + 5.1 + 10 + 6.4 = 41. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Sagar Cements Ltd reported ₹706 Cr of revenue in the Jun 26 quarter, +5.2% year on year. That is the 5th straight quarter of year-on-year growth. Over 10 years it has compounded at 13.4% a year. The last full year, FY26, came in at ₹2,650 Cr. The last four reported quarters add to ₹2,686 Cr.

FY26 revenue came in at ₹2,650 Cr (+17.4% on the year), capping 10 years at 13.4% compound. The latest quarter (Jun 26) printed ₹706 Cr, +5.2% year on year — the 5th consecutive quarter of year-over-year growth.

FY26 revenue ₹2,650 Cr (+17.4% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
13.4% a year over 10 years
RevenueYoY growth
2.9k84%2.1k59%1.4k34%7168.4%0−17%₹ Cr%₹2,65017.4%FY16FY21FY26
2.9k84%2.1k59%1.4k34%7168.4%0−17%₹ Cr%₹2,65017.4%FY16FY21FY26
Jun 26: ₹706 Cr (+5.2% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
5th straight quarter of growth
Revenue (quarterly)YoY growth
85030%63717%4253.8%212−9.5%0−23%₹ Cr%₹7065.2%Sep 23Dec 24Jun 26
85030%63717%4253.8%212−9.5%0−23%₹ Cr%₹7065.2%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +14.1% growth against the decade's 13.4% — the current year is running in line with its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +13.4% over the last 4 quarters against +3.1%/yr over the last 8 — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Sagar Cements Ltd's operating margin is 10.0% in the Jun 26 quarter, −8.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 6.0% to 29.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 10.0%, −8.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 6.0%–29.0%.

🚨 Why the margin moved: operating margin went −7.8 pp year on year while gross margin went −5.9 pp — the loss came mostly from the gross line: input costs and pricing.

FY26: 11.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 6.0–29.0% band over 13 years
operating marginYoY change (pp)
31%15%24%7.8%18%0.5%11%−6.8%4.2%−14%%%11%5%FY09FY20FY26
31%15%24%7.8%18%0.5%11%−6.8%4.2%−14%%%11%5%FY09FY20FY26
Jun 26: 10.0% operating margin (−8.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
19%11%15%6.2%11%1.0%7.1%−4.2%3.1%−9.4%%%10%−8%Sep 23Dec 24Jun 26
19%11%15%6.2%11%1.0%7.1%−4.2%3.1%−9.4%%%10%−8%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Sagar Cements Ltd posted a net loss of ₹28.0 Cr in the Jun 26 quarter. The full FY26 year was a loss of ₹1.0 Cr. That loss is 4.0% of the quarter's revenue. The same quarter a year earlier earned ₹7.0 Cr. 9 of the last 12 reported quarters were loss-making.

Jun 26 profit was ₹−28.0 Cr, −500.0% year on year. On the full year, FY26 printed ₹−1.0 Cr (null).

FY26 profit ₹−1.0 Cr (null YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
218696%101308%−16−81%−132−469%−249−857%₹ Cr%₹−1−750%FY16FY21FY26
218696%101308%−16−81%−132−469%−249−857%₹ Cr%₹−1−750%FY16FY21FY26
Jun 26: ₹−28.0 Cr (−500.0% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
114−37%64−217%14−397%−37−578%−87−758%₹ Cr%₹−28−500%Sep 23Dec 24Jun 26
114−37%64−217%14−397%−37−578%−87−758%₹ Cr%₹−28−500%Sep 23Dec 24Jun 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 253% of Sagar Cements Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹216 Cr of operating cash against ₹−1.0 Cr of profit. After ₹353 Cr of capital spending, ₹−137 Cr was left as free cash.

FY26: operating cash of ₹216 Cr against reported profit of ₹−1.0 Cr, leaving free cash of ₹−137 Cr after ₹353 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 253% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹216 Cr vs profit ₹−1.0 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY22/FY23 reflects an acquisition year — point shown clipped.
253% of 3-year profit arrived as cash
Operating cashNet profitFree cash
44927092−87−266₹ Cr₹216₹−1₹−137FY16FY21FY26
44927092−87−266₹ Cr₹216₹−1₹−137FY16FY21FY26
FY26: CFO = 2,188% of profit (three-year rate 253%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash; outlier years shown pinned.
Conversion100%
316%258%200%142%84%%300%FY16FY21FY26
316%258%200%142%84%%300%FY16FY21FY26

Why conversion sits at 253%: the cash cycle stretched 140 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: the bigger cash user is investment — capital spending ran 1.7× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Sagar Cements Ltd's cash conversion cycle runs 7 days in FY26, up from −133 days in FY21. Capital spending ran ₹1,138 Cr over the last 3 years. At FY26 sales of ₹2,650 Cr each day of that cycle holds about ₹7.3 Cr, so roughly ₹51.0 Cr sits inside the business at any moment.

FY26: debtors at 31 days, inventory at 227 days — roughly 7.5 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 7 days, looser than FY21's −133.

The full loop: cash goes out to suppliers and production on day 0; stock waits 227 days to sell; customers pay about 31 days after that; and suppliers themselves are paid at 251 days — netting out to the 7-day cycle.

In money terms: at FY26 sales of ₹2,650 Cr, each day of the cycle holds about ₹7.3 Cr — so the 7-day loop keeps roughly ₹51.0 Cr sitting inside the business at any moment.

FY26: a 7-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
+140 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
570375180−16−211days7d227d31d251dFY09FY17FY20FY23FY26
570375180−16−211days7d227d31d251dFY09FY20FY26

On the investment side: capital spending of ₹1,138 Cr over the last 3 fiscal years against ₹685 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹116 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹353 Cr, work-in-progress ₹116 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
9727294862430₹ Cr₹353₹116FY10FY18FY21FY23FY26
9727294862430₹ Cr₹353₹116FY10FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Sagar Cements Ltd earns a ROCE of 2% in FY26. That is up from a trough of −2% in FY25. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 0.0% net margin on 0.59× asset turns.

FY26 ROCE is 2%, recovered from a FY25 trough of −2% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 0.0% net margin × 0.59× asset turns × 2.64× balance-sheet leverage ≈ 0.0% on equity. Margin does its share; leverage is a meaningful part of the equation.

FY26: ROCE 2% Return on capital employed by fiscal year, % (line). 12-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY25's −2%
ROCEWACC
20%14%8.0%2.2%−3.6%%2%FY09FY17FY20FY23FY26
20%14%8.0%2.2%−3.6%%2%FY09FY20FY26

The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 75% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.

Sagar Cements Ltd carries ₹1,708 Cr of borrowings against ₹1,693 Cr of equity in FY26, a debt-to-equity of 1.01. Operating profit covers the interest bill 2×. Over 5 years borrowings went from ₹809 Cr to ₹1,708 Cr. Capital spending ran ₹1,138 Cr across the last 3 of those years.

FY26: borrowings of ₹1,708 Cr against equity of ₹1,693 Cr — a debt-to-equity of 1.01. Operating profit covers the interest bill 2×. Over 5 years borrowings went from ₹809 Cr to ₹1,708 Cr while capital spending ran ₹1,138 Cr in just the last 3 — part of the build-out is riding on borrowed money.

FY26: borrowings ₹1,708 Cr at 1.01× equity Borrowings by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 13-year window. Quarterly balance-sheet history is not held for India — annual is the honest resolution.
the debt trajectory
BorrowingsDebt-to-equity
1.8k1.3×1.4k1.1×9220.9×4610.7×00.4×₹ Cr×₹1,7081.01×FY09FY17FY20FY23FY26
1.8k1.3×1.4k1.1×9220.9×4610.7×00.4×₹ Cr×₹1,7081.01×FY09FY20FY26

The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 75% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Domestic institutions added 1.3 points of Sagar Cements Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 18.4% of the company. Foreign institutions moved −1.0 points over the same window, to 1.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Domestic institutions: +1.3 points over 8 quarters to 18.4%; Foreign institutions: −1.0 points over 8 quarters to 1.6%; Promoters: +0.0 points over 8 quarters to 48.3%.

Why the register moved: domestic institutions drove it (+1.3 points), absorbed on the other side by foreign institutions (−1.0 points) — steady accumulation by institutions reading the same numbers this page reads.

Fiscal-year ends: promoters +0.0 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
52%39%25%11%−2.1%%48.3%1.7%18.5%31.5%Mar 24Mar 25Mar 26
52%39%25%11%−2.1%%48.3%1.7%18.5%31.5%Mar 24Mar 25Mar 26
Domestic institutions added 1.3 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
52%39%25%11%−2.1%%48.3%1.6%18.4%31.7%Jun 23Dec 24Jun 26
52%39%25%11%−2.1%%48.3%1.6%18.4%31.7%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Sagar Cements Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Cement
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Star Cement LtdSTARCEMENT 76.0/100Favorable setup90% evidence ASLEEP 29.9/35 Revenue 19.4% · PAT 100% · OPM change 2 pp 88% evidence 22.4/25 ROCE 16.7% · OPM 27% 100% evidence 11.3/20 P/E 20.4× · PEG 1.11 100% evidence 12.4/20 RS sector 13.8% · RS bench -13.2% · 1Y -12.5%1 of 10 weeks ahead 70% evidence
Exact sum: 29.9 + 22.4 + 11.3 + 12.4 = 76 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2NCL Industries LtdNCLIND 69.7/100Favorable setup83% evidence FADING 25.3/35 Revenue 1.8% · PAT 100% · OPM change 7 pp 83% evidence 18.0/25 ROCE 14.5% · OPM 13% 95% evidence 15.0/20 P/E 6.3× · PEG — 50% evidence 11.4/20 RS sector 2.1% · RS bench -6.3% · 1Y -18.8%2 of 12 weeks ahead 100% evidence
Exact sum: 25.3 + 18 + 15 + 11.4 = 69.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3UltraTech Cement LtdULTRACEMCO 63.1/100Mixed-positive evidence76% evidence TURNING 21.9/35 Revenue 17.2% · PAT 26.7% · OPM change -1 pp 95% evidence 17.1/25 ROCE 12.7% · OPM 20% 76% evidence 9.2/20 P/E 40.7× · PEG — 50% evidence 14.9/20 RS sector 17% · RS bench -1.4% · 1Y -2.8%0 of 10 weeks ahead 70% evidence
Exact sum: 21.9 + 17.1 + 9.2 + 14.9 = 63.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Mangalam Cement LtdMANGLMCEM 62.9/100Mixed-positive evidence96% evidence FADING 21.6/35 Revenue 4.6% · PAT 100% · OPM change 0 pp 88% evidence 11.7/25 ROCE 11% · OPM 11% 100% evidence 16.0/20 P/E 17.5× · PEG 0.6 100% evidence 13.6/20 RS sector 24.1% · RS bench 14.9% · 1Y 31.3%5 of 12 weeks ahead 100% evidence
Exact sum: 21.6 + 11.7 + 16 + 13.6 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Rain Industries LtdRAIN 62.5/100Mixed-positive evidence64% evidence BREAKING OUT 22.9/35 Revenue 14.4% · PAT 100% · OPM change 5 pp 62% evidence 9.4/25 ROCE 8.3% · OPM 15% 76% evidence 10.2/20 P/E 24.9× · PEG — 15% evidence 20.0/20 RS sector 61.8% · RS bench 49.7% · 1Y 43.6%12 of 12 weeks ahead 100% evidence
Exact sum: 22.9 + 9.4 + 10.2 + 20 = 62.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Orient Cement LtdORIENTCEM 58.2/100Mixed-positive evidence93% evidence ASLEEP 17.6/35 Revenue -12.1% · PAT -19.3% · OPM change 3 pp 100% evidence 16.9/25 ROCE 16.5% · OPM 24% 100% evidence 16.1/20 P/E 13.2× · PEG 0.25 65% evidence 7.6/20 RS sector -12% · RS bench -20.1% · 1Y -45.9%0 of 12 weeks ahead 100% evidence
Exact sum: 17.6 + 16.9 + 16.1 + 7.6 = 58.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Dalmia Bharat LtdDALBHARAT 53.4/100Mixed-positive evidence94% evidence ASLEEP 13.0/35 Revenue 7.6% · PAT 0.4% · OPM change -3 pp 100% evidence 12.8/25 ROCE 7.6% · OPM 21% 100% evidence 15.3/20 P/E 30.7× · PEG 0.72 100% evidence 12.3/20 RS sector 12.6% · RS bench -11.9% · 1Y -19.3%0 of 10 weeks ahead 70% evidence
Exact sum: 13 + 12.8 + 15.3 + 12.3 = 53.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
8Shree Cement LtdSHREECEM 51.8/100Mixed-positive evidence97% evidence BREAKING OUT 15.0/35 Revenue 12.6% · PAT 9.9% · OPM change -5 pp 95% evidence 13.0/25 ROCE 10.3% · OPM 20% 95% evidence 9.2/20 P/E 57.7× · PEG 0.96 100% evidence 14.6/20 RS sector 5.1% · RS bench -3.7% · 1Y -15.8%3 of 12 weeks ahead 100% evidence
Exact sum: 15 + 13 + 9.2 + 14.6 = 51.8 · Decision use: Price leads the evidence: RS versus the benchmark is -3.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
9JSW Cement LtdJSWCEMENT 50.8/100Thin evidence · provisional51% evidence TURNING 18.6/35 Revenue 12% · PAT -80% · OPM change 5 pp 83% evidence 12.1/25 ROCE 11.1% · OPM 19% 76% evidence 10.1/20 P/E 27.8× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y -8.9%5 of 10 weeks ahead 0% evidence
Exact sum: 18.6 + 12.1 + 10.1 + 10 = 50.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
10K C P LtdKCP 49.4/100Mixed-negative evidence77% evidence ASLEEP 13.5/35 Revenue 1.9% · PAT 8.7% · OPM change 1 pp 83% evidence 16.1/25 ROCE 12.2% · OPM 17% 95% evidence 13.9/20 P/E 10.3× · PEG — 50% evidence 5.9/20 RS sector -14% · RS bench -9.4% · 1Y -23.5%3 of 11 weeks ahead 70% evidence
Exact sum: 13.5 + 16.1 + 13.9 + 5.9 = 49.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
11HeidelbergCement India LtdHEIDELBERG 48.6/100Mixed-negative evidence100% evidence ASLEEP 14.5/35 Revenue 6.6% · PAT 2.6% · OPM change -4 pp 100% evidence 14.7/25 ROCE 14.7% · OPM 11% 100% evidence 13.7/20 P/E 28.5× · PEG 0.82 100% evidence 5.7/20 RS sector -5.1% · RS bench -13.3% · 1Y -28.1%0 of 12 weeks ahead 100% evidence
Exact sum: 14.5 + 14.7 + 13.7 + 5.7 = 48.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
12J K Cements LtdJKCEMENT 48.1/100Mixed-negative evidence94% evidence TURNING 11.2/35 Revenue 15.9% · PAT -7.1% · OPM change -5 pp 100% evidence 16.4/25 ROCE 15.1% · OPM 16% 100% evidence 8.1/20 P/E 43.1× · PEG 1.46 100% evidence 12.4/20 RS sector 10.4% · RS bench -7.1% · 1Y -16%0 of 10 weeks ahead 70% evidence
Exact sum: 11.2 + 16.4 + 8.1 + 12.4 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13The Ramco Cements LtdRAMCOCEM 47.3/100Mixed-negative evidence90% evidence ASLEEP 20.6/35 Revenue 6% · PAT 100% · OPM change 1 pp 88% evidence 13.2/25 ROCE 6.1% · OPM 14% 100% evidence 1.2/20 P/E 732× · PEG 4.14 100% evidence 12.3/20 RS sector 11.1% · RS bench -10.1% · 1Y -19.7%0 of 10 weeks ahead 70% evidence
Exact sum: 20.6 + 13.2 + 1.2 + 12.3 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14JK Lakshmi Cement LtdJKLAKSHMI 47.3/100Mixed-negative evidence65% evidence ASLEEP 17.4/35 Revenue 9.2% · PAT 49.6% · OPM change -5 pp 83% evidence 13.9/25 ROCE 12% · OPM 14% 76% evidence 10.6/20 P/E 17.6× · PEG — 15% evidence 5.4/20 RS sector -8.2% · RS bench -23.6% · 1Y -40.3%0 of 10 weeks ahead 70% evidence
Exact sum: 17.4 + 13.9 + 10.6 + 5.4 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Nuvoco Vistas Corporation LtdNUVOCO 47.1/100Mixed-negative evidence87% evidence TURNING 21.0/35 Revenue 9.5% · PAT 100% · OPM change 0 pp 100% evidence 9.6/25 ROCE 7.1% · OPM 18% 100% evidence 4.8/20 P/E 29.7× · PEG 8.14 65% evidence 11.7/20 RS sector 3.6% · RS bench -5% · 1Y -16.5%4 of 10 weeks ahead 70% evidence
Exact sum: 21 + 9.6 + 4.8 + 11.7 = 47.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16India Cements LtdINDIACEM 45.4/100Mixed-negative evidence75% evidence ASLEEP 21.3/35 Revenue 7% · PAT 100% · OPM change 7 pp 74% evidence 3.8/25 ROCE 1.2% · OPM 15% 100% evidence 5.4/20 P/E 91.4× · PEG — 50% evidence 14.9/20 RS sector 20% · RS bench -2% · 1Y 10.8%0 of 10 weeks ahead 70% evidence
Exact sum: 21.3 + 3.8 + 5.4 + 14.9 = 45.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Deccan Cements LtdDECCANCE 43.7/100Mixed-negative evidence70% evidence ASLEEP 22.6/35 Revenue 20.6% · PAT 100% · OPM change -3 pp 83% evidence 7.9/25 ROCE 3.3% · OPM 8.1% 95% evidence 9.1/20 P/E 43.4× · PEG — 15% evidence 4.1/20 RS sector -12.9% · RS bench -29.1% · 1Y -47.7%0 of 10 weeks ahead 70% evidence
Exact sum: 22.6 + 7.9 + 9.1 + 4.1 = 43.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18ACC LtdACC 42.5/100Mixed-negative evidence94% evidence ASLEEP 9.1/35 Revenue 11.6% · PAT -21.1% · OPM change -5 pp 100% evidence 9.9/25 ROCE 11.2% · OPM 8% 100% evidence 16.7/20 P/E 13.4× · PEG 0.92 100% evidence 6.8/20 RS sector -6.7% · RS bench -16.8% · 1Y -26.5%0 of 10 weeks ahead 70% evidence
Exact sum: 9.1 + 9.9 + 16.7 + 6.8 = 42.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
19Birla Corporation LtdBIRLACORPN 41.0/100Mixed-negative evidence94% evidence ASLEEP 17.4/35 Revenue 3.9% · PAT 44.6% · OPM change -1 pp 100% evidence 10.4/25 ROCE 9.8% · OPM 13% 100% evidence 8.8/20 P/E 12.3× · PEG 3.92 100% evidence 4.4/20 RS sector -14% · RS bench -17.4% · 1Y -37.4%3 of 9 weeks ahead 70% evidence
Exact sum: 17.4 + 10.4 + 8.8 + 4.4 = 41 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Sagar Cements Ltdthis pageSAGCEM 41.0/100Mixed-negative evidence66% evidence ASLEEP 19.5/35 Revenue 13.4% · PAT 79.7% · OPM change -8 pp 95% evidence 5.1/25 ROCE 2% · OPM 10% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 6.4/20 RS sector -8.1% · RS bench -16.3% · 1Y -28.1%0 of 10 weeks ahead 70% evidence
Exact sum: 19.5 + 5.1 + 10 + 6.4 = 41 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Ambuja Cements LtdAMBUJACEM 38.9/100Mixed-negative evidence82% evidence ASLEEP 9.4/35 Revenue 7.1% · PAT -5.9% · OPM change -2 pp 95% evidence 11.0/25 ROCE 5.6% · OPM 17% 76% evidence 12.6/20 P/E 22.8× · PEG — 50% evidence 5.9/20 RS sector -7.2% · RS bench -15.1% · 1Y -29.5%0 of 12 weeks ahead 100% evidence
Exact sum: 9.4 + 11 + 12.6 + 5.9 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Saurashtra Cement LtdSAURASHCEM 38.8/100Mixed-negative evidence76% evidence ASLEEP 19.7/35 Revenue 8.4% · PAT 87.5% · OPM change -5 pp 83% evidence 4.8/25 ROCE 2.5% · OPM 6% 95% evidence 9.5/20 P/E 30.9× · PEG — 15% evidence 4.8/20 RS sector -16.6% · RS bench -24.6% · 1Y -41.9%0 of 12 weeks ahead 100% evidence
Exact sum: 19.7 + 4.8 + 9.5 + 4.8 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Prism Johnson LtdPRSMJOHNSN 38.2/100Mixed-negative evidence69% evidence ASLEEP 12.1/35 Revenue 6.3% · PAT -33.3% · OPM change -2 pp 83% evidence 5.9/25 ROCE 5.9% · OPM 8% 76% evidence 8.6/20 P/E — · PEG — 35% evidence 11.6/20 RS sector 14.3% · RS bench -20.9% · 1Y -32.2%1 of 10 weeks ahead 70% evidence
Exact sum: 12.1 + 5.9 + 8.6 + 11.6 = 38.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24BIGBLOC Construction LtdBIGBLOC 36.7/100Thin evidence · provisional59% evidence ASLEEP 15.4/35 Revenue 26.2% · PAT -80% · OPM change -1.6 pp 62% evidence 5.8/25 ROCE 1.8% · OPM 7.3% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 5.5/20 RS sector -9.7% · RS bench -17.9% · 1Y -24.7%3 of 10 weeks ahead 70% evidence
Exact sum: 15.4 + 5.8 + 10 + 5.5 = 36.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
25Shree Digvijay Cement Co. LtdSHREDIGCEM 31.2/100Adverse evidence81% evidence ASLEEP 10.8/35 Revenue 19.6% · PAT -35% · OPM change -3.5 pp 95% evidence 8.2/25 ROCE 6.4% · OPM 8.7% 95% evidence 6.1/20 P/E 59.4× · PEG — 50% evidence 6.1/20 RS sector -12.4% · RS bench -10.9% · 1Y -15.8%4 of 10 weeks ahead 70% evidence
Exact sum: 10.8 + 8.2 + 6.1 + 6.1 = 31.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Shiva Cement LtdSHIVACEM 36.5/100Thin evidence · provisional42% evidence 18.1/35 Revenue 19.7% · PAT -47.1% · OPM change 15 pp 40% evidence 5.4/25 ROCE -3% · OPM 1% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 3.0/20 RS sector -27.5% · RS bench -36.4% · 1Y -54.1%0 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 18.1 + 5.4 + 10 + 3 = 36.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Sagar Cements Ltd's share price today?

Sagar Cements Ltd trades at ₹174, −27.8% over the past year. The company is valued at ₹2,274 Cr. The stock sits at 11% of its 52-week range of ₹160–₹294, −9.6% versus its 200-day average. On the tape, the price is in a downtrend, 35 weeks in. — as of 31 July 2026.

What were Sagar Cements Ltd's latest quarterly results?

Sagar Cements Ltd reported revenue of ₹706 Cr and a net loss of ₹28.0 Cr for the Jun 26 quarter. Revenue rose 5.2% and profit fell 500.0% year on year. Earnings per share were ₹−1.77. The operating margin was 10.0%, 8.0 pp lower than a year earlier. — as of 31 July 2026.

What is Sagar Cements Ltd's revenue?

Sagar Cements Ltd reported revenue of ₹706 Cr in the Jun 26 quarter, +5.2% year on year. For the full FY26 fiscal year, revenue was ₹2,650 Cr (+17.4%). Over the last 10 years revenue compounded at 13.4% a year. — as of 31 July 2026.

What is Sagar Cements Ltd's profit?

Sagar Cements Ltd earned ₹−28.0 Cr of net profit in the Jun 26 quarter, −500.0% year on year. Full-year FY26 profit was ₹−1.0 Cr. The operating margin ran 10.0% in the latest quarter. — as of 31 July 2026.

What is Sagar Cements Ltd's market cap?

Sagar Cements Ltd's market capitalisation is ₹2,274 Cr at a share price of ₹174. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

What is Sagar Cements Ltd's P/E ratio?

Sagar Cements Ltd trades at a P/E of 127.8×, at the 79th percentile of its own 8-year range, against a long-run median of 31.6×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.

Does Sagar Cements Ltd pay a dividend?

Not in its latest year — Sagar Cements Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 9 of its last 13 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.

Is Sagar Cements Ltd overvalued?

On its own history, Sagar Cements Ltd looks expensive against its own history: its P/E of 127.8× sits at the 79th percentile of its 8-year range (long-run median 31.6×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.

Is Sagar Cements Ltd growing?

Not right now — Sagar Cements Ltd's latest numbers are shrinking: latest-quarter revenue +5.2% year on year, profit −500.0%, and the margin −8.0 pp at 10.0%. The earnings engine currently reads: deteriorating — as of 31 July 2026.

How is Sagar Cements Ltd performing?

Sagar Cements Ltd is in a downtrend, 35 weeks in. Its latest quarter's revenue rose 5.2% and profit fell 500.0% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 17 weeks. This describes what the data did, not a rating. — as of 31 July 2026.

Is Sagar Cements Ltd in an uptrend?

No — the price is in a downtrend (week 35 of stage 4), trading −9.6% versus its 200-day average and at 11% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Is Sagar Cements Ltd beating the market?

Not lately — on a trailing-13-week view Sagar Cements Ltd is currently behind the NIFTY 500 (17 weeks and counting; last ahead the week of 2026-05-08), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +129% against the NIFTY 500's +276% — behind the index over the full window. — as of 31 July 2026.

Will Sagar Cements Ltd's share price go up?

This page publishes no price forecast for Sagar Cements Ltd. What it measures instead: the share price is ₹174, the price is in a downtrend 35 weeks in. Its P/E of 127.8× sits at the 79th percentile of its own 8-year range. — as of 31 July 2026.

Who owns Sagar Cements Ltd?

Promoters hold 48.3% of Sagar Cements Ltd, foreign institutions 1.6%, domestic institutions 18.4% and the public 31.7% (latest quarter). The biggest move on the register over the last two years: Domestic institutions added 1.3 points over 8 quarters. — as of 31 July 2026.

Does Sagar Cements Ltd have too much debt?

It carries real leverage — Sagar Cements Ltd's debt-to-equity is 1.01, and operating profit covers the interest bill 2×. FY26 borrowings were ₹1,708 Cr against equity of ₹1,693 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.

What is Sagar Cements Ltd's capex?

Sagar Cements Ltd spent ₹1,138 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹353 Cr, with ₹116 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.

What is Sagar Cements Ltd's cash flow?

Sagar Cements Ltd generated ₹216 Cr of operating cash flow in FY26 and ₹−137 Cr of free cash flow after ₹353 Cr of capital spending. Reported profit that year was ₹−1.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.

Is Sagar Cements Ltd's profit real cash?

Yes — over the last 3 fiscal years, 253% of Sagar Cements Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹216 Cr against reported profit of ₹−1.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.

Where is Sagar Cements Ltd in its business cycle?

Sagar Cements Ltd's FY26 operating margin was 11.0%, against a 13-year band of 6.0%–29.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 10.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the Sagar Cements Ltd story?

Biggest watch item: the P/E sits at the 79th percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is Sagar Cements Ltd a stock worth studying right now?

This is not investment advice. The machine read: Sagar Cements Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI